Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis

Immune checkpoint inhibitors (ICIs) have shown potential to improve the prognosis of patients with brain metastasis (BM) caused by advanced cancers. However, controversies still exist in regard to its survival benefits. In the present work, a time series-based meta-analysis based on the phase I/II/I...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xingjiang, Yu, Hui, Zheng, Yunliang, Zhang, Qiao, Lin, Meihua, Wang, Jialei, Qiu, Yunqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606910/
https://www.ncbi.nlm.nih.gov/pubmed/33194639
http://dx.doi.org/10.3389/fonc.2020.564382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606910/
https://www.ncbi.nlm.nih.gov/pubmed/33194639
http://dx.doi.org/10.3389/fonc.2020.564382

Ejemplares similares